These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 1006315)

  • 1. [Study on the action of tobramycin (Nebcine) in the urological milieu].
    Bonnaud P; Camey M
    Sem Hop Ther; 1976 Mar; 52(3):165-70. PubMed ID: 1006315
    [No Abstract]   [Full Text] [Related]  

  • 2. [Purulent infection in current antibacterial treatment of urological patients].
    Pytel'AIa ; Goligorskiĭ SD
    Urol Nefrol (Mosk); 1971; 36(3):3-9. PubMed ID: 5145077
    [No Abstract]   [Full Text] [Related]  

  • 3. Tobramycin-cephalothin treatment in leukaemic and neutropenic patients with severe infection.
    Papayannis AG; Thomopoulos D; Voulgaris E; Scliros P; Gardikas C
    J Antimicrob Chemother; 1977 Jul; 3(4):311-5. PubMed ID: 893240
    [No Abstract]   [Full Text] [Related]  

  • 4. [The use of tobramycin in severe infections (author's transl)].
    Babinet P; Bricaire F; Tancrede C; Goulon M
    Sem Hop; 1978 Oct 18-25; 54(33-36):1049-54. PubMed ID: 220716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of tobramycin in an internal medicine and nephrology service].
    Dequiedt P; Vanhille P; Tacquet A
    Lille Med; 1976 Apr; 21(4 Suppl 2):389-92. PubMed ID: 957858
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical therapeutic assessment of tobramycin (Nebramycin factor 6).
    Limson BM; Hipolito EF; Piga SA; Aquino A
    Curr Ther Res Clin Exp; 1976 Jul; 20(1):19-23. PubMed ID: 821701
    [No Abstract]   [Full Text] [Related]  

  • 7. [Better use of tobramycin in the hospital milieu: technics of applied pharmokinetics].
    Le Verge R; Javaudin L; Cormier M; Pinault A; Guesnier LR
    Sem Hop Ther; 1976; 52(5-6):299-307. PubMed ID: 968492
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical evaluation of the preparation Obracin].
    Machalski M; Szygua J; Maślankiewicz A
    Wiad Lek; 1982 Jun; 35(6):379-84. PubMed ID: 7123925
    [No Abstract]   [Full Text] [Related]  

  • 9. [Tobramycin. Bacteriological studies and clinical activity in urinary and extra-urinary infections].
    Abbate GF; Alagia I; Gattoni A; Leonessa V; Manguso L; Altucci P
    G Ital Chemioter; 1977; 24(1-2):33-7. PubMed ID: 615760
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacokinetics of tobramycin (Brulamycin) in young and old age].
    Ludwig E; Arr M; Magyar T; Graber H
    Orv Hetil; 1982 Sep; 123(38):2357-9. PubMed ID: 7145401
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tobramycin in severely ill patients with various types of infection].
    Otero Puime A; Pintado Otero R; García García JA; Ruiz Castro R; Nuño Gil L; Díaz Lavado T; Aduado Matorras A; de Frutos Herranz M
    Rev Esp Anestesiol Reanim; 1976 Nov; 23(6):462-71. PubMed ID: 1019405
    [No Abstract]   [Full Text] [Related]  

  • 12. Topical tobramycin and gentamicin sulfate in the treatment of ocular infections: multicenter study.
    Cagle G; Davis S; Rosenthal A; Smith J
    Curr Eye Res; 1981-1982; 1(9):523-34. PubMed ID: 7341065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic results and tolerance of tobramycin in childhood].
    Lo Iacono F; Malizia R; Agnello D; Maltese I
    Pediatria (Napoli); 1979 Mar; 87(1):91-103. PubMed ID: 514747
    [No Abstract]   [Full Text] [Related]  

  • 14. Update on good use of injectable aminoglycosides, gentamycin, tobramycin, netilmycin, amikacin. Pharmacological properties, indications, dosage, and mode of administration, treatment monitoring.
    Agence française de sécurité sanitaire des produits de santé
    Med Mal Infect; 2012 Jul; 42(7):301-8. PubMed ID: 22770656
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of cefmetazole and piperacillin with or without tobramycin for infections in patients with hematological disorders.
    Nagao T; Komatsuda M; Yamauchi K; Nozaki H; Arimori S
    Tokai J Exp Clin Med; 1981 Oct; 6(4):415-20. PubMed ID: 6459664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective double-blind controlled clinical study of sisomicin versus tobramycin.
    Schieker KR; Hofmann HF
    Pharmatherapeutica; 1981; 2(8):499-503. PubMed ID: 7019928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of tobramycin in single daily doses in urological surgery].
    Tigano G; Andrisani C
    Minerva Urol; 1983; 35(2):149-52. PubMed ID: 6633477
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of septicemia and severe infections with a cefradine-tobramycin combination].
    Gouin F; Charrel CT; Pedrant G; Morel M; Seguin F; Bourque G
    Ann Anesthesiol Fr; 1976; 17(1):37-43. PubMed ID: 984519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Microbiological effectiveness, pharmacokinetics and clinical use of tobramycin].
    Graber H; Arr M; Deutsch T; Ludwig E; Magyar T
    Orv Hetil; 1980 Jan; 121(4):213-7. PubMed ID: 7375095
    [No Abstract]   [Full Text] [Related]  

  • 20. [Tobramycin in inflammations of the small pelvis].
    Kralj B
    Jugosl Ginekol Opstet; 1978; 18(3-4):335-42. PubMed ID: 757252
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.